Program Presentations

MassMEDIC's Annual Conference, Annual MedTech Investors Conference and informational programs throughout the year feature presentations conducted by leading medical device industry executives, thought leaders, researchers, policy makers and management experts. The following is a library of presentations and reports from past MassMEDIC programs and events.

 

December 9, 2011

FDA Update 2011

EU Update: MDD & IVDD
Glenn Emelock, Senior Partner-The CRO Group, Inc.
Mitigating Medical Device Risk through Human Factors
Christina Mendat, PhD, Radius Product Development
Revisions to the 510(k) Program-The Year in Review
Lana A. Gladstein, Pepper Hamilton LLP
November 3, 2011

Patent Reform: What MedTech Companies Need to Know

Patent Reform: What MedTech Companies Need to Know
David J. Dykeman, Esq. Patent Attorney & Shareholder, Greenberg Traurig, LLP
Patent Portfolios that Attract Investment
Omar Amirana, MD, Allied Minds, Inc.
October 31, 2011

KOREA-Medical Device Market and Rising Interests in R&D

KOREA-Medical Device Market and Rising Interests in R&D
Young Kim, President-Synex Consulting, Ltd. Seoul, Korea
September 23, 2011

What Green Group Purchasing Organizations Expect from the Medical Device Industry

Trends in Health Care Sustainability
Janet Brown, Practice Greenhealth
September 16, 2011

Reimbursement Update Conference

Global Evidence and Reimbursement Strategies
Stephen Hull, Hull Associates
The Netherlands Life Sciences Gateway to Europe
Katja Berkhout, Netherlands Foreign Investment Agency | Boston, MA
June 10, 2011

Harnessing the Indian Tiger – MedTech Market Entry Strategies for India

Harnessing the Indian Tiger
Ian Bussey, Managing Director, Nortons India
May 13, 2011

Use of Social Media During Regulatory Uncertainty

Legal Considerations: Industry Use of Social Media
Stephanie Philbin, Goodwin Procter LLP
March 31, 2011

A New World Order for Health Care: Payment Reform – Accountable Care Organizations-Comparative Effectiveness

Current Status of Implementaion of the Health Care Reform Law
Stephen H. Cooper, Government Relations Counselor
Healthcare Reform: Implications for the Medical Device Industry
Charles Matthews, Vice President, Boston Healthcare
March 3, 2011

The Promise of Combination Products

Drug-Device Combination Products
Peter D. Noymer, Ph.D., Vice President, Product R&D, Alexza Pharmaceuticals
The IP Landscape for Combination Products
Jason Honeyman, Shareholder, Wolf Greenfield & Sacks, P.C.
Regulatory Challenges Facing Combination Products
Mary Beth Henderson, Ph.D., Principal Advisor, Regulatory and Clinical Research Institute (RCRI)
« Older Entries